Skip to content
Home/Companies/Biotech/IO Biotech
IB

IO Biotech

Biotech·Denmark·Active·7yr hold

IO Biotech is a healthcare company, headquartered in France.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns IO Biotech?

IO Biotech is currently owned by Eurazeo through Kurma Biofund III (2017 vintage), since 2019. Across its history, IO Biotech has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Eurazeo
Most recent investor
Eurazeo
Kurma Biofund III · 2017 · Healthcare
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Kurma Partners and Eurazeo since 2019.
Co-invest · 2 holders · 2019 · present
Kurma Partners
Kurma PartnersActive
2019 · present · Kurma Biofund I · 2009 · VC
MOIC
–
Eurazeo
EurazeoActive
2019 · present · Kurma Biofund III · 2017 · Healthcare
MOIC
–

More from Kurma Biofund III

Other portfolio companies in the same fund.

ImCheck
Exited 2025
BiotechFrance· 2020
to
Amolyt Pharma
Exited 2024
BiotechFrance· 2019
to
Ermium
Active
BiotechFrance· 2019
Pharvaris
Active
BiotechNetherlands· 2019
Vivet
Active
BiotechFrance· 2019
Orphazyme
Active
BiotechDenmark· 2017

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings